Treatment of children with phenylketonuria using a phenylalanine-free protein hydrolysate (Albumaid XP)
| Autor: | Melanie M. Hunt, Helen K. Berry, Donald J. O'Grady, B S Sutherland, M H Fogelson |
|---|---|
| Rok vydání: | 1976 |
| Předmět: |
Mental development
Male medicine.medical_specialty Phenylketonurias Protein Hydrolysates Phenylalanine Medicine (miscellaneous) Hydrolysate Child Development Internal medicine Medicine Humans Protein hydrolysates Amino Acids Nutrition and Dietetics business.industry Free protein Body Weight Infant Body Height Endocrinology Child Preschool Female business Energy Metabolism |
| Zdroj: | The American journal of clinical nutrition. 29(4) |
| ISSN: | 0002-9165 |
| Popis: | Albumaid XP, a phenylalanine-free protein hydrolysate, was used for treatment of five phenylketonuric infants born between January, 1970, and September, 1972. The results were compared with those obtained from the five infants most recently treated with Lofenalac in our clinic prior to 1970. Treatment was begun by 2 months of age in all instances. Satisfactory physical growth and mental development were achieved using either Albumaid XP or Lofenalac, and there were no major differences in the outcomes with either treatment. The two protein sources may be used interchangeably for treatment of phenylketonuria. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|